Skip to content

CONMED CNMD United States — Long-Lived Assets

Other geography segments

MEXICO
$22.9M

Similar metrics at other companies

Edgewell Personal Care logo
EPCUnited States — Long-Lived Assets
$223.7M-1.8%
Blackbaud logo
BLKBUnited States — Long-Lived Assets
$80.79M-31.3%
Atkore logo
ATKRUnited States — Long-Lived Assets
$614.37M-9.9%
Azenta logo
AZTAUnited States — Long-Lived Assets
$116.19M
BlackLine logo
BLUnited States — Long-Lived Assets
$11.01M-36.7%
Synaptics logo
SYNAUnited States — Long-Lived Assets
$559.5M+7.0%

Other financials

Income statement

See full
Revenue$317.0M-1.3%
Gross profit$183.4M+3.2%
Operating income$25.4M+59.3%
Net income$13.8M+129%
EPS (diluted)$0.45+137%

Balance sheet

See full
Cash & equivalents$35.0M-1.3%
Total debt$862.6M-3.6%
Total equity$1.0B+4.1%
Total assets$2.3B+0.8%

Cash flow

See full
Operating cash flow$13.5M-67.6%
CapEx$2.9M-23.5%
Free cash flow$10.6M-72.0%

Valuation

See full
Market cap$1.07B-34.0%
Enterprise value$1.89B-23.5%
P/E19.4×+5.8×
P/S0.8×-0.5×

Profitability

See full
Gross margin55.2%-1.0pp
Operating margin8.2%-5.6pp
Net margin4%-5.0pp
FCF margin9%-3.5pp

Returns & leverage

See full
Return on equity5.5%-7.5pp
Debt / equity0.8×-0.1×
Current ratio2.3×0.0×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:NoncurrentAssets.

The official record: CONMED’s 10-K, filed February 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's united states — long-lived assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CONMED's united states — long-lived assets?
CONMED (CNMD) reported united states — long-lived assets of $150.8M in Q4 2025.
What does united states — long-lived assets mean?
This metric measures the carrying value of non-current, tangible, and intangible assets physically located or utilized within the United States operations. It reflects the capital intensity required to support domestic manufacturing, distribution, and research infrastructure. Monitoring this balance helps investors assess the company's commitment to domestic production capacity and the efficiency of its capital allocation strategy within its primary market.